Robbins Farley LLC Astrazeneca PLC Transaction History
Robbins Farley LLC
- $233 Million
- Q3 2025
A detailed history of Robbins Farley LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Robbins Farley LLC holds 54,149 shares of AZN stock, worth $4.84 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
54,149
Previous 26,567
103.82%
Holding current value
$4.84 Million
Previous $1.86 Million
123.81%
% of portfolio
1.79%
Previous 0.9%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...